Health Condition 1: T630- Toxic effect of snake venom
Conditions
Interventions
Intervention1: Intervention in the second half of the study involves animal study to develop a snake venom diagnostic kit.: The predominant component of snake venom will be injected to mice at LD50 an
Sponsors
ICMR
Eligibility
Inclusion criteria
Inclusion criteria: Around 3ml of blood sample will be collected from the victims of snake bite before administration of anti snake venom.
Exclusion criteria
Exclusion criteria: Snake bite victims who have been already administered with anti snake venom.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify the composition of venom of each species Common in this region.Timepoint: 12 months and 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To develop a diagnostic test to find out specific snake venom.Timepoint: 2nd year - Animal experiment for developing antibodies against venom component. 3rd year- Development of a venom diagnostic kit 4th year- kit validation 5th year - Data analysis. | — |
Countries
India
Contacts
Public ContactV Poovazhagi
Institute of Child Health and Hospital for Children
Outcome results
None listed